WallStreetZenWallStreetZen

NASDAQ: ANIK
Anika Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Anika Therapeutics revenue was $119.91M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was -$1.3M, down 103.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ANIK annual revenue was $119.9M, with -0.7% growth year-over-year.

ANIK past revenue growth

How has ANIK's revenue growth performed historically?

Company
-0.73%
Industry
10.74%
Market
20.27%
ANIK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ANIK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ANIK's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ANIK revenue history

Current Revenue
$119.9M
Current Earnings
-$56.4M
Current Profit Margin
-47%

Be the first to know when ANIK announces revenue.

ANIK Revenue History By Year

ANIK Yearly RevenueANIK RevenueANIK ChangeANIK Revenue Growth
2024-12-31$119.91M-$885.00k-0.73%
2023-12-31$120.79M$6.97M+6.12%
2022-12-31$113.83M-$33.97M-22.98%
2021-12-31$147.79M$17.34M+13.29%
2020-12-31$130.46M$15.85M+13.83%
2019-12-31$114.61M$9.06M+8.58%
2018-12-31$105.56M-$7.87M-6.93%
2017-12-31$113.42M$10.04M+9.71%
2016-12-31$103.38M$10.38M+11.16%
2015-12-31$93.00M-$12.60M-11.93%
2014-12-31$105.60M$30.51M+40.64%
2013-12-31$75.08M$3.72M+5.22%
2012-12-31$71.36M$6.58M+10.16%
2011-12-31$64.78M$9.22M+16.60%
2010-12-31$55.56M$15.42M+38.42%
2009-12-31$40.14M$4.36M+12.17%
2008-12-31$35.78M$4.95M+16.06%
2007-12-31$30.83M$3.99M+14.86%
2006-12-31$26.84M-$2.99M-10.04%
2005-12-31$29.83M$3.37M+12.73%
2004-12-31$26.47M$11.06M+71.81%
2003-12-31$15.40M$2.22M+16.81%
2002-12-31$13.19M$1.88M+16.58%
2001-12-31$11.31M-$5.02M-30.75%
2000-12-31$16.34M$2.51M+18.15%
1999-12-31$13.83M$895.28k+6.92%
1998-12-31$12.93M$975.03k+8.16%
1997-12-31$11.96M$10.74M+886.38%
1996-12-31$1.21MN/AN/A

1 of 2

Anika Therapeutics Revenue FAQ

What was ANIK's revenue last quarter?

On Invalid Date, Anika Therapeutics (NASDAQ: ANIK) reported Q4 2024 revenue of -$1.29 million up 55.5% year over year. In the same quarter last year, Anika Therapeutics's revenue was -$2.90 million.

What was Anika Therapeutics's revenue in 2024?

Anika Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $119.91 million, a 0.73% decrease year over year.

How much does Anika Therapeutics make in a day?

Based on Anika Therapeutics annual revenue for the past five years, ANIK makes an average of $346,727.12 per day.

What was Anika Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Anika Therapeutics's revenue has grown -0.73% year over year. This is 11.47 percentage points lower than the US Medical Devices industry revenue growth rate of 10.74%. Anika Therapeutics's revenue in the past year totaled $119.91 million.

How much does Anika Therapeutics make in a year?

Anika Therapeutics's revenue by year for the past five years is:
  • Anika Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $119.91 million, a 0.73% decrease year over year.
  • Anika Therapeutics's annual revenue for Dec 31, 2023 was $120.79 million, a 6.12% increase from 2022.
  • Anika Therapeutics's annual revenue for 2022 was $113.83 million, a 22.98% decrease from 2021.
  • Anika Therapeutics's annual revenue for 2021 was $147.79 million, a 13.29% increase from 2020.
  • Anika Therapeutics's annual revenue for 2020 was $130.46 million, a 13.83% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.